Mark J. Vignola, Chief Financial Officer at Terns Pharmaceuticals, Inc. (TERN), sold 10,000 shares at $11.00 ($110K) on 2024-09-10, disclosed to the SEC on 2024-09-12.
Scheduled sale ($110k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TERN | BUY | 2023-12-04 | $3K | — | Filing → |
| TERN | BUY | 2023-06-02 | $14K | — | Filing → |
| TERN | BUY | 2023-02-03 | $4 | — | Filing → |